Clearpoint Neuro Inc

CLPT

$6.80

Closing

▲1.19%

1D

▲0.15%

YTD

Market cap

$183.44M

52 week high

$10.78

52 week low

$4.17

Volume

31,453

Check if the stock is halal

Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.

Get started from just $3.99/month

Market cap

$183.44M

Analysts' Rating

STRONG BUY

Price Target (Mean)

9.5

Total Analysts

3

P/E

Operating Margin

-84.99%

Beta

1.04

Revenue Growth (Annual)

26.09%

52 week high

$10.78

52 week low

$4.17

Div. Yield

%

EPS Annual Growth

-31.03

Note on Purification and Zakat

  • Purification and Zakat (for long-term investing) calculations are in USD per share and based on AAOIFI methodology. AAOIFI requires purification every financial period (e.g. quarterly). 
  • If you follow S&P Shariah’s Dividend-only purification, then remove the impure income % from the dividends you receive. No purification required for non-dividend paying stocks, according to S&P Shariah.
  • For Zakat, if you did not invest in a company from a long term perspective, then consider the shares as trading goods and give 2.5% of the total value if a year has passed on them. 

Company Profile

ClearPoint Neuro, Inc. is a commercial-stage medical device company. The Company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain. Its ClearPoint system is an integrated system comprised of hardware components, disposable components and intuitive, menu-driven software. Its hardware components consist primarily of a head fixation frame, computer workstation, and in-room monitor. Its disposable components for its ClearPoint system consist primarily of its SmartFrame trajectory device, a hand controller and related accessories, and its SmartFlow Cannula. Its ClearPoint system software guides the physician in surgical planning, device alignment, navigation to the target and procedure monitoring. Its ClearPoint Prism Neuro Laser Therapy System is indicated for use to necrotize or coagulate soft tissue through interstitial irradiation or thermal therapy for neuro applications under 3.0T magnetic resonance imaging (MRI) guidance.